» Articles » PMID: 27940084

Considerations for the Development of in Vitro Dissolution Tests to Reduce or Replace Preclinical Oral Absorption Studies

Overview
Journal Eur J Pharm Sci
Specialties Chemistry
Pharmacology
Date 2016 Dec 13
PMID 27940084
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmaceutical development of new chemical entities can be hampered by their solubility and/or dissolution limitations. Currently, these properties are characterised mostly during in vivo pre-clinical studies. The development of appropriate in vitro methods to study the solubility and dissolution properties in preclinical species would lead to a significant reduction or replacement of the animal experiments at this stage of development. During clinical development, media simulating the human gastrointestinal tract fluids are commonly used and a similar approach mimicking laboratory animals' gastrointestinal tract fluids would impact on the preclinical stage of development. This review summarises the current knowledge regarding the gastrointestinal physiology of the most common laboratory animals, and animal simulated gastric and intestinal media are proposed.

Citing Articles

Biopharmaceutical Characterization and Stability of Nabumetone-Cyclodextrins Complexes Prepared by Grinding.

Klaric D, Soldin Z, Vincze A, Szollath R, Balogh G, Jug M Pharmaceutics. 2025; 16(12.

PMID: 39771473 PMC: 11679744. DOI: 10.3390/pharmaceutics16121493.


Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography.

Liu Q, Zan M, Huang H, Su H, Zhang W, Ma L Asian J Pharm Sci. 2024; 19(6):100966.

PMID: 39640054 PMC: 11617939. DOI: 10.1016/j.ajps.2024.100966.


An In Vitro Model to Investigate the Potential of Solid Dispersions to Form Pharmacobezoars.

Gierke H, Schaefer K, Gerlich L, Willmann A, Bialetzki V, Boeck G Pharmaceutics. 2022; 14(12).

PMID: 36559103 PMC: 9785156. DOI: 10.3390/pharmaceutics14122608.


In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin A.

Becker T, Krome A, Vahdati S, Schiefer A, Pfarr K, Ehrens A Pharmaceutics. 2022; 14(8).

PMID: 36015283 PMC: 9414514. DOI: 10.3390/pharmaceutics14081657.


A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.

Martinez M, Wu F, Sinko B, Brayden D, Grass M, Kesisoglou F AAPS J. 2022; 24(3):61.

PMID: 35501528 DOI: 10.1208/s12248-022-00713-1.